$1.64 Billion is the total value of Reynders McVeigh Capital Management, LLC's 231 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EQR | Exit | Equity Residentialsh ben int | $0 | – | -2,210 | -100.0% | -0.01% | – |
WST | Exit | West Pharmaceutical Svsc Inc | $0 | – | -465 | -100.0% | -0.01% | – |
AJG | Exit | Gallagher Arthur J & Co | $0 | – | -1,254 | -100.0% | -0.01% | – |
GILD | Exit | Gilead Sciences Inc | $0 | – | -3,095 | -100.0% | -0.01% | – |
FND | Exit | Floor & Decor Holdings Inc Clcl a | $0 | – | -1,700 | -100.0% | -0.01% | – |
T | Exit | AT&T Inc | $0 | – | -9,155 | -100.0% | -0.01% | – |
RPM | Exit | RPM Intl Inc | $0 | – | -2,400 | -100.0% | -0.01% | – |
TEL | Exit | Te Connectivity Ltd Reg | $0 | – | -1,491 | -100.0% | -0.01% | – |
AWK | Exit | American Water Works Co Inc | $0 | – | -1,275 | -100.0% | -0.01% | – |
SHOP | Exit | Shopify Inc Cl Acl a | $0 | – | -197 | -100.0% | -0.02% | – |
CRL | Exit | Charles River Laboratories Int | $0 | – | -700 | -100.0% | -0.02% | – |
GSK | Exit | GlaxoSmithKline PLC Sp ADRsponsored adr | $0 | – | -6,780 | -100.0% | -0.02% | – |
SWK | Exit | Stanley Black & Decker Inc | $0 | – | -1,824 | -100.0% | -0.02% | – |
NFLX | Exit | Netflix Inc | $0 | – | -621 | -100.0% | -0.02% | – |
ESGD | Exit | iShares ESG MSCI EAFEesg aw msci eafe | $0 | – | -4,810 | -100.0% | -0.02% | – |
XLNX | Exit | Xilinx Inc | $0 | – | -78,495 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MasterCard Inc Cl A | 42 | Q3 2023 | 4.8% |
ROCKWELL AUTOMATION INC | 42 | Q3 2023 | 4.2% |
PROCTER & GAMBLE CO | 42 | Q3 2023 | 5.9% |
CVS Health Corporation | 42 | Q3 2023 | 5.7% |
CANADIAN NATL RY CO | 42 | Q3 2023 | 3.5% |
JOHNSON & JOHNSON | 42 | Q3 2023 | 4.0% |
DANAHER CORP DEL | 42 | Q3 2023 | 4.6% |
Novartis AG Sp ADR | 42 | Q3 2023 | 4.0% |
ILLUMINA INC | 42 | Q3 2023 | 3.3% |
Walt Disney Co | 42 | Q3 2023 | 3.6% |
View Reynders McVeigh Capital Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-07 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-15 |
View Reynders McVeigh Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.